ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

NYU Langone Medical Center Laura and Isaac Permlutter Cancer Center, New York

Icahn School of Medicine at Mt. Sinai, New York

Eastchester Center for Cancer Care, The Bronx

North Shore Hematology Oncology Associates, East Setauket

Roswell Park Comprehensive Cancer Center, Buffalo

Gettysburg Cancer Center, Gettysburg

St. Luke's University, Bethlehem

Maryland Oncology Hematology, Rockville

University of Maryland, Baltimore

John Hopkins Kimmel Cancer Center, Baltimore

Duke University Medical Center, Durham

Virginia Oncology Associates, Hampton

University of North Carolina-Chapel Hill, Chapel Hill

Levine Cancer Institute, Charlotte

Carolina Urologic Research Center, Myrtle Beach

Greenville Hospital System, Institute for Translational Oncology Research, Greenville

University of Florida, Jacksonville

Mount Sinai Comprehensive Cancer Center, Miami

H. Lee Moffitt Cancer Center & Research Institute, Tampa

Ohio State University - James Cancer Hospital and Solove Research Institute, Columbus

Toledo Clinic Cancer Center, Toledo

Indiana University- Simon Cancer Center, Indianapolis

Henry Ford Health System, Detroit

Rush University Medical Center, Chicago

University of Illinois Hospital and Health Systems, Chicago

GU Research Network, Omaha

Tulane University Health Sciences Center, New Orleans

Texas Oncology- Tyler, Tyler

Texas Oncology- Fort Worth, Fort Worth

Texas Oncology - Central Austin Cancer Center, Austin

Rocky Mountain Cancer Centers, Aurora

University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora

New Mexico Cancer Center, Albuquerque

Comprehensive Cancer Centers of Nevada, Las Vegas

UCLA, Los Angeles

Beverly Hills Cancer Center (BHCC), Beverly Hills

John Wayne Cancer Inst., Duarte

Compass Oncology - East, Tualatin

Williamette Valley Cancer Institute and Research Center, Eugene

Alaska Urological Institute, Anchorage

Dana Farber Cancer Institute, Boston